USA – Mirae Asset Capital Life Science, a Boston, MA- and San Francisco, CA-based venture capital firm investing in private biotechnology companies, has emerged from stealth with its inaugural $50m fund.
Mirae Asset Capital Life Science Inception I, LP, is supported by a diverse global investor base comprised of Limited Partners within the Mirae Asset Financial Group.Read more on VCWire.tech, our new website dedicated to the tech venture capital industry.19/01/2024
